确定miRNAs作为神经母细胞瘤中良好预后的预测标记
Hiroaki Kondo1, Ken Kikuchi1,2, Akimasa Tomida1
1Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
概括
四种microRNAs (miRNAs) 显示为神经母细胞瘤 (NB) 良好的预后的生物标志物. 这些miRNAs参与神经元分化,并可能有助于评估神经母细胞瘤治疗的有效性.
科学领域:
- 儿科瘤学 儿科瘤学
- 分子生物学分子生物学
- 生物标志物发现发现
背景情况:
- 神经母细胞瘤 (NB) 是一种常见的儿童癌症,结果各不相同.
- 目前NB的预后标志物有限.
- 微RNAs (miRNAs) 正在成为NB的潜在预后指标.
研究的目的:
- 确定新的microRNA (miRNA) 生物标志物,以促进神经母细胞瘤 (NB) 的良好预后.
- 研究特定miRNAs在NB细胞分化中的作用.
主要方法:
- 血清微RNA (miRNA) 阵列分析是在按风险分层的神经母细胞瘤 (NB) 患者样本上进行的.
- 用网红酸 (RA) 处理NB细胞系以诱导分化.
- 评估了外体中的miRNA表达和NB细胞中miRNA模仿者的影响.
主要成果:
- 四个miRNAs (miR-4716-5p,miR-4305,miR-4285,miR-3692*) 被确定为低风险NB的候选标记.
- 网红酸治疗诱导了神经元分化,并增加了这四种miRNAs的表达.
- 在NB细胞分化过程中,外体度和外体内这四种miRNA的水平在NB细胞分化过程中增加.
结论:
- 鉴定的四种miRNAs作为潜在的生物标志物用于神经母细胞瘤 (NB) 的良好预后.
- 这些miRNA似乎在神经元分化过程中发挥作用.
- 研究的miRNAs可能为NB治疗中的治疗评估提供了一个新的工具.
相关概念视频
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K


